Military use of drugs not yet approved by the FDA for CW/BW defense lessons from the Gulf War

Military use of drugs not yet approved by the FDA for CW/BW defense lessons from the Gulf War / Richard A. Rettig.

The confrontation that began when Iraq invaded Kuwait in August 1990 brought with it the threat that chemical and biological weapons might be used against the more than half a million military personnel the United States deployed to the region. To protect these troops from such threats, the Departme...

Full description

Saved in:
Bibliographic Details
Main Author: Rettig, Richard A.
Corporate Authors: United States. Department of Defense. Office of the Secretary of Defense, National Defense Research Institute (U.S.)
Format: eBook
Language:English
Published: Santa Monica, Calif. : RAND, 1999.
Series:Gulf War illnesses series.
Ebsco e-book purchased.
Subjects:
Chemical warfare > Security measures.
Biological warfare > Security measures.
Gases, Asphyxiating and poisonous > Antagonists.
Vaccines.
Informed consent (Medical law) > United States.
Involuntary treatment > United States.
Persian Gulf War, 1991 > Chemical warfare.
Electronic resources (E-books)
United States > Armed Forces > Medical care.
Electronic books.
Online Access:Click to view e-book
Holy Cross Note:Loaded electronically.
Electronic access restricted to members of the Holy Cross Community.
This was purchased from Ebsco with a single user license.
Login for hold information

‌

Click to view e-book

Online

Holdings details from Online
Call Number: E-Book UG447 .R46 1999
Copy 1 Available

Similar Items